RBISP2

Across TCGA pan-cancer cohorts, RBISP2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RBISP2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RBISP2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RBISP2 is over-expressed in tumor.

BRCA, LUAD, and HNSC are the cancer types where RBISP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBISP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	+0.129	.024	6	view →
LUAD	Female	III,IV	+0.246	.006	4	view →
HNSC	Male	II,III,IV	+0.064	.015	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RBISP2–BRCA

Open the BRCA breakdown →